SageTech Medical is pleased to announce a significant advancement in its mission to lead sustainable anaesthesia. The company has signed a distribution agreement with the Dräger Schweiz AG, a medical device manufacturer and distributor known for its innovative anaesthesia delivery systems. This collaboration will enhance SageTech Medical’s footprint in Europe and support its growth strategy.
The agreement represents a key step in the European commercialisation of SageTech Medical’s SID-Dock, an innovative Class 1 medical device designed to safely and sustainably capture waste anaesthetic gases. The SID-Dock not only supports compliance with recent EU F-Gas legislation but also aligns with the healthcare sector’s increasing focus on greener practices.
Iain Menneer, CEO of SageTech Medical, said:
“We are thrilled to be partnering with Dräger Switzerland. This distribution agreement comes at a crucial time when healthcare providers are prioritising environmental sustainability. Anaesthetic gases, while essential in medicine, are also potent greenhouse gases with a considerable carbon footprint. The SID-Dock offers a practical solution, enabling hospitals and clinics to capture these gases, reduce emissions, and adhere to environmental regulations.”
The collaboration with Dräger Switzerland strengthens SageTech Medical’s European expansion efforts by leveraging Dräger’s extensive market expertise and established infrastructure.
Thomas Kunz, Head of Sales & Service Medical, Dräger Schweiz AG, added:
“We are excited to be the exclusive representative of SageTech in Switzerland. This partnership represents an important step towards sustainability and green anaesthesia. By adding SageTech’s innovative solutions to our portfolio, we are addressing the current trends and are confident that this will enable us to meet the requirements of the market and our customers even better.”
By introducing an advanced gas capture and recycling solution, SageTech Medical is significantly reducing the environmental impact of anaesthetic gases. Additionally, its innovative circular economy approach minimises the carbon footprint linked to the production of virgin anaesthetic agents.
About SageTech Medical
The manufacture of virgin anaesthetic agents and their release as waste volatile gases is highly damaging to the environment and contributes significantly to the total carbon footprint of healthcare. SageTech Medical is a medical device company focused on the research, design, manufacture and distribution of technologies for the capture and recycling of waste volatile anaesthetic agents. SageTech’s mission is to significantly reduce the global release of an estimated 4 million tonnes of carbon dioxide equivalent emission each year from anaesthetic gases used in human and veterinary healthcare. www.sagetechmedical.com
About Dräger
Dräger manufactures medical and safety technology products. In so doing, we protect, support, and save people’s lives around the world in hospitals, with fire departments, emergency services, authorities, and in mining as well as industry. Founded in Lübeck in 1889, Dräger has grown into a worldwide, listed enterprise in its fifth generation as a family-run business. Dräger has more than 16,000 employees worldwide and is present in over 190 countries around the globe. In 2023, the company generated net sales of EUR 3.4 billion. Dräger technology is used all over the world. We operate in around 50 countries with our own sales and service companies directly on location where our customers are. www.draeger.com